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Interleukin-10 (IL-10) is one of the most important anti-inflammatory cytokine produced
during bacterial infection. Two related phenomena explain the importance of IL-10
production in this context: first, the wide range of cells able to produce this cytokine and
second, the wide effects that it causes on target cells. In a previous report we described
opposing roles of IL-10 production during bacterial infection. Overall, during infections
caused by intracellular bacteria or by pathogens that modulate the inflammatory
response, IL-10 production facilitates bacterial persistence and dissemination within the
host. Whereas during infections caused by extracellular or highly inflammatory bacteria,
IL-10 production reduces host tissue damage and facilitates host survival. Given that
these data were obtained using antibiotic susceptible bacteria, the potential application
of these studies to multi-drug resistant (MDR) bacteria needs to be evaluated. MDR
bacteria can become by 2050 a major death cause worldwide, not only for its ability to
resist antimicrobial therapy but also because the virulence of these strains is different
as compared to antibiotic susceptible strains. Therefore, it is important to understand
the interaction of MDR-bacteria with the immune system during infection. This review
discusses the current data about the role of IL-10 during infections caused by major
circulating antibiotic resistant bacteria. We conclude that the production of IL-10
improves host survival during infections caused by extracellular or highly inflammatory
bacteria, however, it is detrimental during infections caused by intracellular bacteria or
bacterial pathogens that modulate the inflammatory response. Importantly, during MDR-
bacterial infections a differential IL-10 production has been described, compared to
non-MDR bacteria, which might be due to virulence factors specific of MDR bacteria that
modulate production of IL-10. This knowledge is important for the development of new
therapies against infections caused by these bacteria, where antibiotics effectiveness is
dramatically decreasing.
Keywords: interleukin-10, multi-drug resistance, bacterial infection, immune response, host–pathogen
interactions
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INTRODUCTION
Infectious diseases caused by pathogenic bacteria have been
historically a major cause of human death. The discovery and
mass production of antibiotics dramatically reduced the mortality
associated to bacterial infections for several years. However, the
golden age of antibiotic seems to be over: according to a report
led by the economist Jim O’Neill, in 2017 around 700,000 deaths
were caused by multi-drug resistant (MDR) bacterial infections.
His prediction, however, indicates that by 2,050 the mortality
associated to MDR-bacterial infections will be around of 10
million (O’Neill, 2016).
Due to this phenomenon, the World Health Organization
(WHO) has classified the most concerning MDR-bacteria
into different groups of priority according with the urgency
to develop new antibiotics and therapies (Tacconelli, 2017).
The critical priority group includes Acinetobacter baumannii,
Pseudomonas aeruginosa, and Mycobacterium tuberculosis. Also,
different species of the Enterobacteriaceae genus, including
Klebsiella pneumoniae, Escherichia coli, are part of this group.
The high priority group includes the pathogenic bacteria
Staphylococcus aureus, Neisseria gonorrhoeae, Salmonella spp.,
among others.
In a previous report we discussed the relevance of the anti-
inflammatory cytokine Interleukin-10 (IL-10) in the immunity
against different pathogenic bacteria (Peñaloza et al., 2016). We
conclude that IL-10 production is required for host survival
during infections caused by extracellular and/or highly pro-
inflammatory bacteria, including Streptococcus pneumoniae,
Pseudomonas aeruginosa, Francisella tularensis, Escherichia coli,
and Mycobacterium tuberculosis (Peñaloza et al., 2016). On
the other hand, IL-10 production impairs host survival during
infections caused by intracellular bacteria or bacterial pathogens
that modulate the inflammatory response, such as Klebsiella
pneumoniae, Bordetella pertussis, Listeria monocytogenes,
Brucella abortus and Salmonella enterica serovar Typhimurium
(Peñaloza et al., 2016).
During extracellular or/and highly pro-inflammatory bacterial
infection, the pathogen mostly neutralizes or eliminates the
immune response effectors. In this context, the production of
IL-10 modulates the immune response intensity and allows
a successful bacterial clearance, without excessive host tissue
damage. Although in some cases the absence of IL-10 makes
the immune response more effective to clear the pathogen, the
damage produced on host tissues is more severe and compromise
host survival (Peñaloza et al., 2016).
The strategies used by intracellular pathogens and/or bacteria
that modulate the inflammatory response are different and
mainly consist in their capacity to evade the immune system
(Bhavsar et al., 2007). In this condition, the production of IL-10
during the infective cycle of these bacteria helps them to evade the
immune response and to disseminate within the host, seriously
impairing host survival.
The studies performed so far that evaluate the role of
IL-10 during bacterial infections have been performed using
antibiotic susceptible bacteria. The conclusions reached in these
reports cannot be translated to MDR-bacteria. Recent data
have described that the immune response against antibiotic
susceptible and MDR strains of the same bacterial specie may
be remarkably different (de Breij et al., 2012; Xiong et al.,
2015). Therefore, it raises two major questions about infections
caused by MDR-bacteria. First: is the available data accurate
enough to predict the role of immune effectors, such as
anti-inflammatory cytokines, during MDR bacterial infections?
And second: is it possible to develop new therapies against
MDR bacteria with the current knowledge? To date, there
are not enough data available to certainly answer both of
these questions. However, in the last years increased efforts
have made possible to understand better the role of some
immune components in the response against different MDR
bacteria.
In this mini-review, we will discuss whether the role of
IL-10 during infections caused by major antibiotic susceptible
bacteria applies to major MDR-bacterial infections. Next,
we will analyze whether MDR-bacteria induce a differential
production of IL-10 as compared to non-MDR bacteria, to finally
discuss about the possible mechanisms that may explain this
difference.
THE OPPOSING ROLE OF IL-10 DURING
MULTI-DRUG RESISTANT BACTERIAL
INFECTION
Carbapenem-resistant Acinetobacter baumannii (A. baumannii)
is an opportunistic, aerobic, Gram-negative, and extracellular
bacteria classified as a critical pathogen by the WHO (Tacconelli,
2017). A. baumannii is able to evade neutrophil mediated killing,
including neutrophil extracellular traps (NETs) degradation
(Kamoshida et al., 2015) or uptake inhibition after adherence
(Kamoshida et al., 2015). This bacterium is commonly associated
to primary health care facilities, causing skin infections,
pneumonia, urinary tract infections and sepsis, mostly in
immunocompromised patients (Lee et al., 2017; Harding et al.,
2018).
One study demonstrated that during A. baumannii
pneumonia, MDR A. baumannii virulence varies significantly
as compared to non-MDR-A. baumannii (de Breij et al., 2012).
Importantly, the production of IL-10 in the lungs was positively
correlated with host survival (de Breij et al., 2012). Another
report supported this observation (Noto et al., 2017). That
report evaluated the role of receptor for advanced glycation end
products (RAGE) during an A. baumannii infection. RAGE−/−
mice are more resistant to a pneumonia caused by non-MDR
A. baumannii (Noto et al., 2017). The elevated survival rate
displayed by RAGE−/− mice is dependent on IL-10. Given
that the neutralization of this cytokine reversed the resistant
phenotype observed in these mice, and at the same time the
administration of recombinant IL-10 improves host survival of
susceptible wild type (WT) mice (Noto et al., 2017).
Carbapenem-resistant Pseudomonas aeruginosa
(P. aeruginosa) is another bacterium classified in the critical
group (Tacconelli, 2017). P. aeruginosa is a Gram-negative
opportunistic pathogenic bacterium able to causes chronic
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respiratory tract infections in patients with cystic fibrosis and
in patients with compromised immune system (Gellatly and
Hancock, 2013). Due to the importance of P. aeruginosa, since
long time ago scientists have started to use clinical isolates to
study host-pathogen interaction, specifically ampicillin resistant
strains (Chmiel et al., 1999, 2002; Parker et al., 2016; Riquelme
et al., 2017). A recent study analyzed cytokine production,
cellular recruitment and bacterial clearance during the first 12 h
during an intraperitoneal infection with four MDR isolates, three
non-MDR isolates and two reference strains of P. aeruginosa
in mice (Gomez-Zorrilla et al., 2017a). MDR isolates induced
a stronger immune response able to clear more efficiently
the infective bacteria at 12 hpi (Gomez-Zorrilla et al., 2017a).
These data help to understand the differences of virulence and
pathogenicity between MDR and not-MDR strains. However,
given that the infection route was intraperitoneally and not
intranasal, we cannot conclude whether the production of IL-10
is beneficial or detrimental during pneumonia caused by MDR
P. aeruginosa in this particular experiment. Despite that, all the
evidences show that IL-10 production protects the host during
P. aeruginosa.
Both Carbapenem-resistant and 3rd generation of
cephalosporin resistant Enterobacteriaceae have also been
categorized in the critical group (Tacconelli, 2017). Within
this group are included Klebsiella pneumonia, Escherichia
coli, Enterobacter spp., Serratia spp., Proteus spp., Providencia
spp. and Morganella spp. Most of the studies performed
on these bacteria are epidemiological (Liñares et al., 2010;
Rojas et al., 2017), genetic (Deleo et al., 2014; Rojas et al.,
2017), or have been focused to understand the mechanisms
involved in the acquisition of antibiotic resistance (Fuzi et al.,
2017; Dhar et al., 2018). However, few studies have been
focused in the analysis of host-pathogen interaction with
MDR-strains. Regarding to that these reports describe the
FIGURE 1 | Proposed mechanisms of enhanced IL-10 production during MDR-bacterial infections and antibiotic treatment. The increased IL-10 production during
MDR-bacteria can possibly be a consequence of (A) an improved ability of bacteria to synthesize polysaccharide capsule or (B) modifications in LPS.
(C) Clarithromycin and probably other antibiotics promote the recruitment of myeloid suppressor cells and IL-10 production.
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immune response against carbapenem-resistant K. pneumoniae
(CRKP) (Tzouvelekis et al., 2013; Xiong et al., 2015; Ahn
et al., 2016). These studies showed that CRKP isolates are
less virulent (Tzouvelekis et al., 2013; Xiong et al., 2015) than
antibiotic susceptible K. pneumoniae strains, but resistant
to neutrophil-mediated clearance (Tzouvelekis et al., 2013;
Ahn et al., 2016; Kobayashi et al., 2016). CRKP showed to be
highly susceptible to human serum (Olonisakin et al., 2016;
DeLeo et al., 2017) and the anti-capsule antibodies generation
helped to innate cells to clear this pathogen in vivo (Kobayashi
et al., 2018). Another important characteristic of CRKP is the
primary role of monocytes in the pathogenesis caused by this
bacterium. For monocytes, at least two different roles have
been described during CRKP infection: some of the monocytes
recruited to the lungs are Monocytic Myeloid-derived cells
(M-MDSCs) (Ahn et al., 2016) probably able to establish
an anti-inflammatory environment, aiding CRKP to evade
the immune response. On the other hand, inflammatory
monocytes are essential to phagocyte and kill CRKP as
well as to activate ILC3s and Th17 response (Xiong et al.,
2016).
Mycobacterium tuberculosis (M. tuberculosis) is another
bacterium included in the critical WHO group. M. tuberculosis
is a rod-shaped bacterium with a cell wall rich in lipids
able to cause chronic and latent infections in the lung tissue
(Glickman and Jacobs, 2001; Bañuls et al., 2015). During non-
MDR M. tuberculosis infections, IL-10 production by neutrophils
is important for host survival (Peñaloza et al., 2016). But there
is not data available that describe the immunity and the role
of IL-10 during MDR M. tuberculosis infection at molecular
level.
Methicillin/Vancomycin-resistant Staphylococcus aureus
and 3rd generation cephalosporin/fluoroquinolone-resistant
Neisseria gonorrhoeae (N. gonorrhoeae) are the only WHO
high priority bacterial species for which the role of IL-10
production has been described (Liu et al., 2013; Leech et al.,
2017). Staphylococcus aureus is an extracellular Gram-positive
bacterium able to cause serious lung (Kitur et al., 2015) and skin
infections (Kitur et al., 2016). Most of host-pathogen interaction
research has been done on Methicillin-resistant S. aureus
(MRSA), and the result of this research is the identification of
bacterial and host factors involved in MRSA infection (Parker
et al., 2016; Leech et al., 2017).
During a MRSA (USA300) infection there is a rapid
production of IL-10 (Leech et al., 2017). The contribution of
this cytokine for host survival varies according the nature of the
infection. During an acute systemic infection, the production
of IL-10 by CD19+CDB220+ cells was required to control the
bacterial dissemination and its production is associated with
host survival (Leech et al., 2017). However, in a sub-cutaneous
infection model, IL-10 produced mostly by MDSCs in the local
wound impairs MRSA clearance, without affecting host survival
(Leech et al., 2017). MRSA infects orthopedic devices. In this
case, the production of IL-10 by MDSCs favors the biofilm
formation on the surface of these devices inducing persistent
infections that do not affect host mortality (Heim et al., 2014,
2015).
Neisseria gonorrhoeae is an obligate Gram-negative human
pathogen (Balthazar et al., 2011; Araneta et al., 2017) causative of
gonorrhea, a sexually transmitted disease (Balthazar et al., 2011;
Araneta et al., 2017). During an intra-vaginal N. gonorrhoeae
infection, the neutralization of IL-10 through the administration
of microspheres improved the clearance of N. gonorrhoeae
and enhanced the polarization to a Th1 response (Liu et al.,
2013). These findings suggest that the production of IL-10 is
detrimental for the immunity against this bacterium (Liu et al.,
2013).
Fluoroquinolone-resistant Salmonella enterica (S. enterica)
is a pathogenic bacterium categorized in the high priority
group with S. aureus and N. gonerrhoeae (Tacconelli, 2017).
S. enterica is a Gram-negative foodborne pathogenic bacterium
(Lamas et al., 2018). Similar to other bacteria, few host-pathogen
interaction studies have been reported for MDR Salmonella
and yet the role of IL-10 during MDR Salmonella infection
remains unknown. However, we have recently reported the
role of IL-10 during an infection with non-MDR-Salmonella
enterica serovar Typhimurium (Salazar et al., 2017). This report
demonstrates that IL-10 produced mostly by T cells impairs
Salmonella clearance and increases host mortality (Salazar et al.,
2017). Further research is needed to evaluate whether MDR-S.
Typhimurium will differentially induce IL-10 production during
infection.
MDR AND NON-MDR BACTERIA
INDUCE DIFFERENTIAL IL-10
PRODUCTION DURING INFECTION
In the previous section, we described that the production of IL-
10 plays a critical role during MDR-bacterial infections. Similar
to infections caused by non-MDR bacteria, the production of
IL-10 may lead to a better or worse outcome depending of
the infecting bacteria. Since the MDR-bacteria and non-MDR
bacteria present different virulence, it is possible to hypothesize
that MDR-bacteria induce differential amounts of IL-10 during
infection. Indeed, several studies corroborate this hypothesis.
For example, ICU patients infected with extensively drug-
resistant (XDR) P. aeruginosa presented elevated amounts of
IL-10 in blood, as compared to patients infected with non-
MDR P. aeruginosa (Gomez-Zorrilla et al., 2017b). Same result
was obtained in a mouse model of P. aeruginosa pneumonia
(Tam et al., 2018). Consistently, patients infected with MDR
M. tuberculosis presented higher amounts of IL-10 in the serum,
as compared to patients infected with non-MDR M. tuberculosis
(Pinheiro et al., 2013). However, another group did not find any
difference in IL-10 production in patients infected with MDR or
non-MDR M. tuberculosis (Eum et al., 2008). Moreover, during
a S. aureus endocarditis model, rabbits infected with MRSA
presented higher amounts of IL-10 as compared to those infected
with Methicillin susceptible S. aureus in the serum (Tsaganos
et al., 2013).
All these data suggest that MDR-bacteria might induce more
IL-10 production than non-MDR bacteria. The only exception
was found in A. baumannii infection, where children infected
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FIGURE 2 | The opposing role of the anti-inflammatory effect of IL-10. During MDR bacterial infections, the suppressive role of IL-10 can lead into two different
outcomes. (Left) Describes that during infections with extracellular and/or pro-inflammatory bacteria, the strong immune response will be essentially modulated by
IL-10, allowing a slow clearance with limited host tissue damage, generating an equilibrium required for host survival. On the contrary, during infections with
intracellular and/or anti-inflammatory bacteria (right), the production of IL-10 together with the bacterial virulence strategies will shut down the immune response,
impairing the bacterial clearance, facilitating the dissemination within the host and at the end, increasing the host mortality rate.
either with MDR A. baumannii presented the same levels of IL-10
as compared with children infected with non-MDR A. baumannii
(Fang et al., 2016).
The next question then is as to how MDR-bacteria induce
higher levels of IL-10. It is well known that antibiotic resistance
not only involves the acquisition of hydrolytic enzymes, but also
includes changes in proteins structure or expression of genes
involved in virulence such as porins, two-component systems and
others (Beceiro et al., 2013). Polysaccharide capsule (Figure 1A),
present in bacteria such as K. pneumoniae, P. aeruginosa,
A. baumannii, S. aureus, among other bacteria, is an important
determinant for antimicrobial peptides and Polymyxin B
resistance (Llobet et al., 2008). An increased ability to produce
capsule may be an adaptation against antibiotics. Interestingly,
capsule recognition by pattern recognition receptors (PRRs)
triggers IL-10 production in myeloid cells (Peñaloza et al.,
2016). MgrB is an important regulator of gene expression
in K. pneumoniae, deletion of mgrB increases the resistance
to collistin and Polymyxin B by the remodeling of lipid A
mediated by the PhoPQ system (Kidd et al., 2017). This increased
resistance is associated with increased virulence and reduced
TNF-α production (Kidd et al., 2017). Lipid A remodeling has
also been observed in MDR P. aeruginosa, also dependent on the
activity of the PhoPQ system (Barrow and Kwon, 2009; Lee et al.,
2017). PmrAB, another two-component system, is also involved
in LPS modification and promotes antibiotic resistance in S.
enterica and P. aeruginosa (Gunn et al., 2000; Barrow and Kwon,
2009). Similarly, A. baumannii resistance to Polymyxin B is
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mediated by mutations in lpxA, lpxC and lpxD. These mutations
lead to the loss of LPS by altering the biosynthesis of the lipid
A (Moffat et al., 2010) and induce a weaker immune response.
It is unknown whether LPS modification by MDR-bacteria leads
to higher production of IL-10. This possibility is highly probable,
given that LPS recognition by TLR4 induces IL-10 production in
myeloid cells (Figure 1B) (Peñaloza et al., 2016).
Multi-drug resistant N. gonorrhoeae carries the opa gene (Hess
et al., 2012). Opa inhibits the proliferation of CD4+ T cells and
B cells in mice (Boulton and Gray-Owen, 2002), increases the
expression of PD-L1 and stimulates the production of IL-10 (Zhu
et al., 2012).
Even though the treatments against MDR bacteria are limited,
they mostly consist of antibiotic administration. A recent report
describe that Clarithromycin promotes the recruitment of anti-
inflammatory myeloid cells able to produce IL-10, Arginase-1
and iNOS to the lung tissue and the spleen (Namkoong et al.,
2018). The recruitment of these cells to the lung protects the host
during pneumococcal pneumonia and in LPS endotoxin shock
(Namkoong et al., 2018). It is unknown whether other antibiotics
also induce the production of IL-10 or other anti-inflammatory
mediators. This would be an interesting hypothesis to evaluate
(Figure 1C).
CONCLUSION
In the last years, increasing data support the idea that IL-
10 production drives the development of a successful immune
response during bacterial infection. However, whether IL-10
production is beneficial or not for host survival depends of the
pathogen nature and the immune response associated to the
infection (Peñaloza et al., 2016).
The rapid emergence of MDR bacteria is a major concern
and has pushed the research community to invest more efforts
in studying these bacteria. Most of the research done on
MDR bacteria has been focused on epidemiological and genetic
characterization (Liñares et al., 2010; Deleo et al., 2014; Rojas
et al., 2017); and limited numbers of studies have been focused
in the understanding of host-pathogen interaction. The most
important reason for the existence of this gap is the high amount
of data available regarding non-MDR strains and the assumption
that virulence and pathogenicity of MDR and non-MDR bacteria
are similar. Recent reports show that pathogenicity and virulence
can be remarkably different between MDR and non-MDR strains
(de Breij et al., 2012; Tzouvelekis et al., 2013; Xiong et al.,
2015).
The data discussed in this mini-review support the dual
role of IL-10, previously described for non-MDR can also
be found during MDR bacterial infection. For non-MDR
bacterial infection IL-10 production is required for host survival
during infections caused by extracellular and/or highly pro-
inflammatory bacteria. Conversely, for MDR bacterial infection,
IL-10 impairs host survival and bacterial clearance during
intracellular and/or weak pro-inflammatory bacteria. During
A. baumannii and MRSA infection, the production of IL-
10 is required for host survival. Both bacteria have acquired
different virulence factors that allow them to neutralize the
host immune response at different stages. In this scenario,
a hyperactive immune response may occur, being IL-10
essential to modulate the intensity of it (Figure 1, left
panel).
As we discussed previously, most of the studies about host–
pathogen interaction of P. aeruginosa has been done using
ampicillin resistant strains. In this scenario the production of IL-
10 seems to be required for host survival, however, whether these
data can be translated to carbapenem-resistant P. aeruginosa is
unknown and more studies need to be done.
S. enterica and N. gonorrhoeae are both intracellular
pathogens, either way; IL-10 absence and/or neutralization
improve the host immunity against these microbes and increase
host survival (Figure 2, right panel). Overall, these data is
consistent with our initial hypothesis.
Carbapenem-resistant K. pneumoniae is a special case.
K. pneumoniae is an extracellular bacterium that induces a weak
pro-inflammatory response (Ahn et al., 2016). Published data
show that during non-MDR K. pneumoniae infection, IL-10
production facilitates bacterial dissemination and impairs host
survival (Peñaloza et al., 2016). Several reports show that the
virulence and pathogenicity of MDR strains are reduced as
compared to non-MDR strains (Tzouvelekis et al., 2013; Xiong
et al., 2015; Ahn et al., 2016). It is quite remarkable that even
though CRKP doses typically used in mice studies are around
1 × 108 CFUs/mice, WT C57BL/6J are highly resistant to these
infections (Tzouvelekis et al., 2013; Xiong et al., 2015; Ahn et al.,
2016). These bacteria are also resistant to neutrophil-mediated
clearance (Ahn et al., 2016; Kobayashi et al., 2016) and during
CRKP there is a rapid peak of IL-10 production (Ahn et al., 2016).
Taking account all this data, we hypothesize that during CRKP
infection IL-10 is a major immune response modulator required
for host survival (Figure 2, left panel).
One of the most important concerns of this report is the
lack of research regarding host–pathogen interaction on MDR
bacteria. It is clear by the whole community that the golden
age of antibiotics is over, however, the knowledge of how these
bacteria have adapted to the host immune response and how we
can improve it is very limited. Therefore, we believe that more
research in host immunity and bacterial virulence is required to
design new strategies to identify effective therapeutic targets or
strategies.
Finally, it is quite interesting MDR-bacteria stimulates higher
IL-10 production as compared with non-MDR bacteria. We
believe that the differential production of IL-10 may be a
consequence of the changed expression pattern of different
virulence factors displayed by these bacteria. This fact could
explain why in general these bacteria are less virulent and why
higher bacterial dose are commonly used to study host–pathogen
interaction in mice.
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